Palmer 2000.
Trial name or title | Rosiglitazone intervention study on patients with type 1.5 diabetes |
Methods | Randomised controlled trial |
Participants | Antibody positive T2 diabetes, aged 35 to 69 years, no history of ketonuria. |
Interventions | Rosiglitazone or glyburide (SU) |
Outcomes | Fasting and stimulated C peptide, Antibody levels |
Starting date | 2000 |
Contact information | Jerry Palmer, Seattle Institute for Biomedical and Clinical Research, University of Washington. |
Notes |